Delphi Consensus Meeting on Tuesday 26th September 2023 at 7pm (BST)

You may be aware that there is some concern about the compatibility of certain brands of folinic acid with oxaliplatin. A group of pharmacists, on behalf of the British Oncology Pharmacy Association would like to develop a national consensus on the best approach to handling this situation.

They are planning to hold an on-line delphi consensus meeting on Tuesday 26th September 2023 at 7pm (BST). The aim is to review the published information and then (if possible) to reach a consensus. We are looking for UK based:

  • Pharmacists & Pharmacy Technicians with clinical backgrounds where infusional fluorouracil with folinic acid are routinely used
  • Pharmacists & Pharmacy Technicians or other experts from Quality Assurance, Quality Control, Health Informatics and Aseptic backgrounds
  • Pharmacists or Pharmacy Technicians with involvement in medicines procurement
  • Medication Safety Officers
  • Medical or clinical oncologists with significant experience in the design of folinic acid based chemotherapy protocols
  • Other multi-disciplinary team members, including chemotherapy nurses, with relevant expertise

to participate in an on-line meeting lasting up to 90 minutes. The meeting will present an overview of the available data and present a number of proposed solutions to be considered by the audience. The audience will be expected to participate in a series of votes during the meeting. Participation is open to BOPA and non-BOPA members.

The purpose of the meeting would be to produce a document that can be published.

If you would be willing to participate please complete the online registration form here:
https://forms.office.com/e/N1fxvCymex

Participants will be contacted by email with further information nearer the time including login details for the meeting and some pre-reading materials.

Latest News

By BOPA E&T Subcommittee on 12th February 2025

The BOPA Cancer Consultant Pharmacist Credentialing Support Series is back

BOPA are holding a nine-month supportive webinar series for pharmacists who are credentialing as consultant pharmacists with the RPS. First session: Wednesday 26th February 12:30pm Join in this relaxed forum…

Read article
By BOPA research committee on 10th February 2025

SURVEY: Consensus Framework for the Optimal Delivery of Bispecific Antibodies for Patients with Multiple Myeloma

Help Improve Bispecific Antibody Delivery for Multiple Myeloma Patients! The Consensus Framework for the Optimal Delivery of Bispecific Antibodies for Patients with Multiple Myeloma was published November 2024. Created by the…

Read article
By BOPA on 3rd February 2025

UKPPL Board and BOPA Webinar (Wednesday12th Feb 2025): Collaborative Pharmacy Professional Leadership

Wednesday 12th February 2025 16:00 GMT   ‘Enabling us to be the best that pharmacy can be’ webinars will be held across the UK from 3rd to 25th February 2025,…

Read article
By BOPA Committee on 31st January 2025

Publication update: National SACT regimen specific consent forms for bladder cancer

Dear All,   National SACT regimen specific bladder cancer forms have been reviewed and updated. All forms can be found here: www.cruk.org/sact_consent. Please share this update with your clinical teams…

Read article